Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Elliott

Showing results (81-90 of 249) with videos related to

Pageof 25
Sort By:
Lancet (London, England)|December 24, 1977
Acquired cystic disease of kidneyH L Elliott, A I Macdougall, W M Buchanan
British Medical Journal (Clinical Research Ed.)|June 5, 1982
Self-poisoning with sustained-release aminophylline: secondary rise in serum theophylline concentration after charcoal haemoperfusionA D Struthers, H L Elliott, G J Addis
British Journal of Clinical Pharmacology|August 1, 1981
Diuretic dose schedules: is twice daily more effective?H L Elliott, B C Campbell, J R Lawrence
Clinical Pharmacokinetics|October 1, 1993
Enalapril clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships. An overviewR J MacFadyen, P A Meredith, H L Elliott
European Journal of Clinical Pharmacology|January 1, 1984
Pharmacokinetics of endralazineH L Elliott, P A Meredith, J L Reid
Lancet (London, England)|November 25, 1995
Safety of calcium antagonistsH L Elliott, M Epstein, H Haller, et al.
British Medical Journal (Clinical Research Ed.)|January 16, 1982
Epileptiform seizures and electroencephalographic abnormalities as manifestations of digoxin toxicityD J Kerr, H L Elliott, W S Hillis
Journal of Cardiovascular Pharmacology|January 1, 1987
Verapamil and prazosin in essential hypertension: evidence of a synergistic combination?H L Elliott, P A Meredith, J L Reid
Journal of Cardiovascular Pharmacology|January 1, 1981
Labetalol and the management of hypertensionJ L Reid, P A Meredith, H L Elliott
Pharmacological Research|October 1, 1991
The influence of age on the pharmacokinetics of verapamilJ H Ahmed, P A Meredith, H L Elliott
Pageof 25

Showing results (81-90 of 249) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|December 24, 1977
Acquired cystic disease of kidneyH L Elliott, A I Macdougall, W M Buchanan
British Medical Journal (Clinical Research Ed.)|June 5, 1982
Self-poisoning with sustained-release aminophylline: secondary rise in serum theophylline concentration after charcoal haemoperfusionA D Struthers, H L Elliott, G J Addis
British Journal of Clinical Pharmacology|August 1, 1981
Diuretic dose schedules: is twice daily more effective?H L Elliott, B C Campbell, J R Lawrence
Clinical Pharmacokinetics|October 1, 1993
Enalapril clinical pharmacokinetics and pharmacokinetic-pharmacodynamic relationships. An overviewR J MacFadyen, P A Meredith, H L Elliott
European Journal of Clinical Pharmacology|January 1, 1984
Pharmacokinetics of endralazineH L Elliott, P A Meredith, J L Reid
Lancet (London, England)|November 25, 1995
Safety of calcium antagonistsH L Elliott, M Epstein, H Haller, et al.
British Medical Journal (Clinical Research Ed.)|January 16, 1982
Epileptiform seizures and electroencephalographic abnormalities as manifestations of digoxin toxicityD J Kerr, H L Elliott, W S Hillis
Journal of Cardiovascular Pharmacology|January 1, 1987
Verapamil and prazosin in essential hypertension: evidence of a synergistic combination?H L Elliott, P A Meredith, J L Reid
Journal of Cardiovascular Pharmacology|January 1, 1981
Labetalol and the management of hypertensionJ L Reid, P A Meredith, H L Elliott
Pharmacological Research|October 1, 1991
The influence of age on the pharmacokinetics of verapamilJ H Ahmed, P A Meredith, H L Elliott
Pageof 25